Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021

Addressing Reemergence of Diphtheria among Adolescents through Program Integration in India

Kiran Kumar MaramrajComments to Author , M.L. Kavitha Latha, Rukma Reddy, Samir V. Sodha, Suneet Kaur, Tanzin Dikid, Sukrutha Reddy, S.K. Jain, and Sujeet Kumar Singh
Author affiliations: National Centre for Disease Control, New Delhi, India (K.K. Maramraj, S. Kaur, T. Dikid, S.K. Jain, S.K. Singh); Ronald Ross Institute of Tropical and Communicable Diseases, Hyderabad, India (M.L.K. Latha); State Health Department, Telangana, India (R. Reddy, S. Reddy); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.V. Sodha)

Main Article

Table 1

Immunization status of 99 study patients with confirmed diphtheria cases, Telangana, India, 2017*

Diphtheria vaccine Based on card information only, no. (%) Based on card information or parental recall, no. (%)
Pentavalent 1 or DTP1 23 (23) 55 (56)
Pentavalent 2 or DTP2 23 (23) 53 (54)
Pentavalent 3 or DTP3 23 (23) 52 (53)
DTP booster 1 21 (21) 44 (44)
DTP booster 2† 17 (18) 35 (36)

*DTP, diphtheria-tetanus-pertussis vaccine.
†Denominator for DTP booster 2 = 96; three 4-year-olds were excluded because they were not eligible for DTP booster 2 based on age.

Main Article

Page created: December 22, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.